Quantcast

Latest Lupus Stories

2010-11-22 05:30:00

DENVER, Nov. 22, 2010 /PRNewswire/ -- On November 20 at the American Society of Nephrology 43rd Annual Meeting, Columbia University Assistant Professor of Clinical Medicine Andrew Bomback, MD, presented results from a patient case series assessing the potential therapeutic value of H.P. Acthar® Gel (repository corticotropin injection) as a treatment for patients with nephrotic syndrome, a kidney disorder characterized by excessive loss of urinary protein. Initial data...

2010-11-16 17:05:00

NEW YORK, Nov. 16, 2010 /PRNewswire-USNewswire/ -- The Lupus Research Institute (LRI) and its National Coalition of state and local lupus organizations are pleased with the U.S. Food and Drug Administration (FDA) Advisory Committee's vote to recommend approval of Benlysta(®) for active systemic lupus erythematosus (SLE), offering patients new found hope for the first approved treatment option in more than 50 years. The U.S. FDA Arthritis Advisory Committee voted 13 to 2...

2010-11-16 16:29:00

WASHINGTON, Nov. 16, 2010 /PRNewswire-USNewswire/ -- Today the U.S. Food and Drug Administration (FDA) Arthritis Advisory Committee voted overwhelmingly (13 to 2) to recommend BENLYSTA® for approval as a treatment for the autoimmune disease lupus. If FDA approved, BENLYSTA would become the first new treatment for lupus in 52 years. While today's vote is a positive step, the FDA still must make a final decision to approve BENLYSTA in the coming weeks. Sandra C. Raymond,...

2010-11-09 20:56:43

Mary Kirkland Center for Lupus Care at Hospital for Special Surgery brings together patient care, education and research The benefits of collaborative, multidisciplinary care of patients with complex autoimmune diseases like lupus and multiple sclerosis are just beginning to be appreciated by physicians. Hospital for Special Surgery in New York will present evidence of the advantages of such a specialized disease center dedicated to comprehensive lupus care at the 74th Annual Meeting of the...

2010-11-09 07:05:00

ATLANTA, Nov. 9, 2010 /PRNewswire/ -- UCB (EURONEXT: UCB) and U.S. based partner Immunomedics Inc. (Nasdaq: IMMU) announced that results from the phase IIb study, EMBLEM(TM), showed that certain doses of epratuzumab were associated with a meaningful and statistically significant* reduction in disease activity in adult patients with moderate to severe active SLE. The EMBLEM(TM) study was designed to evaluate the efficacy and safety of epratuzumab (in combination with immunosuppressants)...

2010-11-08 11:15:38

3 HSS faculty honored as masters at American College of Rheumatology Annual Meeting Hospital for Special Surgery physicians who focus on lupus, scleroderma and related conditions are traveling from New York City to Atlanta this week to share their recent findings at the 74th Annual Scientific Meeting of the American College of Rheumatology (ACR). Special Surgery investigators will present advances that may influence the future of clinical care. Topics include prevention strategies for helping...

2010-11-08 11:13:37

Lupus puts children at higher risk for coronary artery disease when they become adults, but routinely using statins doesn't provide enough benefit to warrant their regular use in children and adolescents, according to the largest study of pediatric lupus patients to date. Lupus is an autoimmune disease that causes widespread inflammation and organ damage. Children with lupus show early signs of atherosclerosis -- the fatty tissue buildup that is the precursor to clogged arteries. Previous...

2010-11-07 00:16:27

Betty Diamond, MD, head of the Center for Autoimmune and Musculoskeletal Disorders at the Feinstein Institute, has collaborated with colleagues at the Burke Cornell Medical Research Institute to identify two distinct mechanisms that explain the how lupus autoantibodies alter brain function and led to such a wide array of neuropsychiatric complaints. Manhasset, NY (Vocus) November 5, 2010 Many patients with systemic lupus erythematosus (SLE) suffer from a variety of neuropsychiatric problems...

2010-10-22 11:00:00

ST CLAIR SHORES, Mich., Oct. 22 /PRNewswire/ -- October is World Lupus Month and Frito-Lay has made it one to remember for Michelle 'Mickey' Wynn, a Lupus Alliance of America Michigan/Indiana Affiliate member. With the threat of eviction looming if Mickey's house did not receive much needed repairs, Frito-Lay rallied its employees and local businesses for a "Motown Makeover" to completely renovate the Lupus survivor's home. "When city officials told me I would be evicted from my home if...

2010-10-18 09:00:00

Pioneering Organization Demonstrates 80% Success Rate by LRI-Funded Researchers, Generates $100 Million in Follow-On Funding in First 10 Years NEW YORK, Oct. 18 /PRNewswire-USNewswire/ -- Today, the Lupus Research Institute (LRI) released results from the organization's first scientific research impact report entitled, "A Decade of Impact in Lupus Research - Driving Discovery through Innovation." The results from the report demonstrate a significant impact in lupus research, which has...


Latest Lupus Reference Libraries

10_727908da8421f900a92d7a25ed6718ea2
2004-10-19 04:45:44

Lupus (the wolf) Constellation -- Lupus belongs to the constellations of the Southern Hemisphere roughly between DECL=-30 degrees and DECL=-55 degrees and RA=14h 20m and RA=16h 15m, respectively. It is located between Centaurus on the western and Scorpius and Norma on the eastern boundary. In the north Lupus borders on Libra, to the south it tops Circinus. As a part of the Milky Way stretches through Lupus it is an interesting part of the sky for simple stargazing with binoculars....

More Articles (1 articles) »
Word of the Day
humgruffin
  • A terrible or repulsive person.
Regarding the etymology of 'humgruffin,' the OED says (rather unhelpfully) that it's a 'made-up word.' We might guess that 'hum' comes from 'humbug' or possibly 'hum' meaning 'a disagreeable smell,' while 'gruffin' could be a combination of 'gruff' and 'griffin.'